NASDAQ:ASRT
Assertio Therapeutics Stock News
$1.07
+0.0500 (+4.90%)
At Close: May 17, 2024
ASRT vs. CTLT: Which Stock Is the Better Value Option?
12:47pm, Thursday, 04'th Aug 2022
ASRT vs. CTLT: Which Stock Is the Better Value Option?
7 Penny Stocks to Buy Before the Bull Market Returns
08:30am, Monday, 01'st Aug 2022
In recent weeks, the stock market has stabilized after June's sell-off, but it may take time before bullishness makes a comeback. Plenty of uncertainty remains, including further interest rate hikes,
Assertio (ASRT) to Report Q2 Earnings: What's in the Cards?
04:20pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Assertio Holdings' (ASRT) second-quarter performance is likely to reflect the sales performance of its marketed drugs and cost savings from the company's restructuring plans.
Hot Penny Stocks To Buy? 4 Under $3 To Watch This Week
11:22pm, Monday, 25'th Jul 2022 PennyStocks
Are you looking for some hot penny stocks to buy this week?…
The post Hot Penny Stocks To Buy? 4 Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Hot Penny Stocks To Buy? 4 Under $3 To Watch This Week
07:22pm, Monday, 25'th Jul 2022
Are you looking for some hot penny stocks to buy this week?
Assertio Holdings, Inc. To Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
12:30pm, Monday, 25'th Jul 2022 GlobeNewswire Inc.
LAKE FOREST, Ill., July 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products
Assertio Holdings, Inc. To Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
08:30am, Monday, 25'th Jul 2022
LAKE FOREST, Ill., July 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products t
Assertio (ASRT) Gains As Market Dips: What You Should Know
10:15pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Assertio (ASRT) closed the most recent trading day at $3.11, moving +1.97% from the previous trading session.
Zacks.com featured highlights Assertio, Mercer International, and LGL
10:34am, Friday, 22'nd Jul 2022 Zacks Investment Research
Assertio, Mercer International, and LGL have been highlighted in this Screen of the Week article.
3 Best Breakout Stocks to Invest in for Attractive Returns
11:25am, Thursday, 21'st Jul 2022 Zacks Investment Research
Assertio (ASRT), Mercer International (MERC) and The LGL Group (LGL) have been selected as the breakout stocks for today.
3 Best Breakout Stocks to Invest in for Attractive Returns
08:33am, Thursday, 21'st Jul 2022
Assertio (ASRT), Mercer International (MERC) and The LGL Group (LGL) have been selected as the breakout stocks for today.
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
03:40pm, Monday, 18'th Jul 2022 Zacks Investment Research
ASRT vs. ZTS: Which Stock Is the Better Value Option?
ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?
01:09pm, Monday, 18'th Jul 2022
ASRT vs. ZTS: Which Stock Is the Better Value Option?
Assertio (ASRT) Gains But Lags Market: What You Should Know
10:15pm, Friday, 15'th Jul 2022 Zacks Investment Research
Assertio (ASRT) closed the most recent trading day at $2.82, moving +0.71% from the previous trading session.
Centene (CNC) Divests Unit to Boost Focus on Core Business
03:48pm, Friday, 15'th Jul 2022 Zacks Investment Research
Centene (CNC) closes the deal to divest its pharmacy business. CNC primarily intends to pursue share repurchases with proceeds received from the transaction.